372910 — Hancom Lifecare Share Price
Last trade - 00:00- KR₩84bn
- KR₩51bn
- KR₩105bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.64 | ||
| Price to Tang. Book | 0.66 | ||
| Price to Free Cashflow | 4.81 | ||
| Price to Sales | 0.82 | ||
| EV to EBITDA | 4.05 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.47% | ||
| Return on Equity | 5.62% | ||
| Operating Margin | 7.15% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 151,841.84 | 121,140.36 | 100,120.11 | 112,779.72 | 104,776.43 | n/a | n/a | 9.49% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -85.08 | +271.66 | -92.7 | +551.64 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hancom Lifecare Inc is a Korea-based company principally engaged in the manufacture of air respirator, gas mask and special purpose clothing. The Company's main products include respirators and components, emergency evacuation masks, general gas masks, industrial masks, military masks, hoods and fire suits, helmets, heat shields, health masks, among others. The Company sells its products within domestic to foreign markets.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 21st, 1971
- Public Since
- August 17th, 2021
- No. of Shareholders
- 42,902
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 27,674,406
- Address
- 53, Jungbu-daero 1960beon-gil,, YONGIN, 17160
- Web
- http://www.hancomlifecare.com
- Phone
- +82 3151839000
- Auditors
- Ernst & Young Han Young
Upcoming Events for 372910
Similar to 372910
Bionote
Korea Exchange - KSE
Dentium Co
Korea Exchange - KSE
SD Biosensor
Korea Exchange - KSE
Shinhung Co
Korea Exchange - KSE
FAQ
As of Today at 21:00 UTC, shares in Hancom Lifecare are trading at KR₩3,115. This share price information is delayed by 15 minutes.
Shares in Hancom Lifecare last closed at KR₩3,115 and the price had moved by -50.56% over the past 365 days. In terms of relative price strength the Hancom Lifecare share price has underperformed the FTSE Developed Asia Pacific Index by -49.99% over the past year.
There is no consensus recommendation for this security.
Find out moreHancom Lifecare does not currently pay a dividend.
Hancom Lifecare does not currently pay a dividend.
Hancom Lifecare does not currently pay a dividend.
To buy shares in Hancom Lifecare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩3,115, shares in Hancom Lifecare had a market capitalisation of KR₩84bn.
Here are the trading details for Hancom Lifecare:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 372910
Based on an overall assessment of its quality, value and momentum Hancom Lifecare is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hancom Lifecare. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -21.19%.
As of the last closing price of KR₩3,115, shares in Hancom Lifecare were trading -16.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hancom Lifecare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,115.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hancom Lifecare's directors